Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Kumar Verma

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Chemistry|July 16, 2021
Computational Modeling of C-Terminal Tails to Predict the Calcium-Dependent Secretion of Endoplasmic Reticulum Resident ProteinsKathleen A Trychta, Bing Xie, Ravi Kumar Verma, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug DiscoveryR N V Krishna Deepak, Ravi Kumar Verma, Yossa Dwi Hartono, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 27, 2021
Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitorsJacqueline Wen Hui Leow, Ravi Kumar Verma, Amos Boon Hao Lim, et al.
Chemical Science|May 19, 2025
Unveiling the molecular basis of selective fluorination of SAM-dependent fluorinasesRavi Kumar Verma, Wan Lin Yeo, Elaine Tiong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Direct and Sequential Bioactivation of Pemigatinib to Reactive Iminium Ion Intermediates Culminates in Mechanism-Based Inactivation of Cytochrome P450 3ALloyd Wei Tat Tang, Wan Wei, Ravi Kumar Verma, et al.
Molecular Pharmacology|July 2, 2021
Differential Reversible and Irreversible Interactions between Benzbromarone and Human Cytochrome P450s 3A4 and 3A5Lloyd Wei Tat Tang, Ravi Kumar Verma, Ren Ping Yong, et al.
Plos Computational Biology|January 17, 2018
The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptorsRavi Kumar Verma, Ara M Abramyan, Mayako Michino, et al.
Nature Communications|February 7, 2018
Gs- versus Golf-dependent functional selectivity mediated by the dopamine D<sub>1</sub> receptorHideaki Yano, Ning-Sheng Cai, Min Xu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2021
Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, et al.
Chembiochem : a European Journal of Chemical Biology|December 12, 2024
A Mn(salen)-Based Artificial Metalloenzyme for Nitrene and Oxene Transfer CatalysisZhennan Liu, Yee-Song Law, Ravi Kumar Verma, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Chemistry|July 16, 2021
Computational Modeling of C-Terminal Tails to Predict the Calcium-Dependent Secretion of Endoplasmic Reticulum Resident ProteinsKathleen A Trychta, Bing Xie, Ravi Kumar Verma, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug DiscoveryR N V Krishna Deepak, Ravi Kumar Verma, Yossa Dwi Hartono, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 27, 2021
Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitorsJacqueline Wen Hui Leow, Ravi Kumar Verma, Amos Boon Hao Lim, et al.
Chemical Science|May 19, 2025
Unveiling the molecular basis of selective fluorination of SAM-dependent fluorinasesRavi Kumar Verma, Wan Lin Yeo, Elaine Tiong, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Direct and Sequential Bioactivation of Pemigatinib to Reactive Iminium Ion Intermediates Culminates in Mechanism-Based Inactivation of Cytochrome P450 3ALloyd Wei Tat Tang, Wan Wei, Ravi Kumar Verma, et al.
Molecular Pharmacology|July 2, 2021
Differential Reversible and Irreversible Interactions between Benzbromarone and Human Cytochrome P450s 3A4 and 3A5Lloyd Wei Tat Tang, Ravi Kumar Verma, Ren Ping Yong, et al.
Plos Computational Biology|January 17, 2018
The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptorsRavi Kumar Verma, Ara M Abramyan, Mayako Michino, et al.
Nature Communications|February 7, 2018
Gs- versus Golf-dependent functional selectivity mediated by the dopamine D<sub>1</sub> receptorHideaki Yano, Ning-Sheng Cai, Min Xu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2021
Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, et al.
Chembiochem : a European Journal of Chemical Biology|December 12, 2024
A Mn(salen)-Based Artificial Metalloenzyme for Nitrene and Oxene Transfer CatalysisZhennan Liu, Yee-Song Law, Ravi Kumar Verma, et al.
Pageof 3